Effector caspases and leukemia

International Journal of Cell Biology

Volumn , Issue , 2011, Pages

  Chen, Guo Qiang ^a   Lu, Ying ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ARACHIDONATE 5 LIPOXYGENASE; CASPASE; CASPASE 10; CASPASE 2; CASPASE 3; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; CISPLATIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; DOXORUBICIN; DUAL SPECIFICITY PHOSPHATASE 2; ETOPOSIDE; FLICE INHIBITORY PROTEIN; GELSOLIN; HYBRID PROTEIN; IMATINIB; LAMIN A; NOTCH1 RECEPTOR; ONCOPROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN BID; PROTEIN KINASE B; RETINOIC ACID RECEPTOR ALPHA; RNA BINDING PROTEIN EWS; TRANSCRIPTION FACTOR RUNX1; UNINDEXED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; APOPTOSIS; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CARCINOGENESIS; CELL DEATH; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CHROMOSOME 17; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; COLORECTAL CARCINOMA; DENDRITIC CELL; ERYTHROBLAST; GENE EXPRESSION; HUMAN; KERATINOCYTE; LEUKEMIA; LEUKEMIA CELL; LEUKEMOGENESIS; MYOBLAST; NERVE FIBER DEGENERATION; NEURAL STEM CELL; NONHUMAN; OSTEOBLAST; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVIEW; STOMACH CARCINOMA; THROMBOCYTE;

MAMMALIA;

EID: 79959438247     PISSN: 16878876     EISSN: 16878884     Source Type: Journal    
DOI: 10.1155/2011/738301     Document Type: Review

References (101)

1. Yuan J., Shaham S., Ledoux S., Ellis H. M., Horvitz H. R., The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 -converting enzyme Cell 1993 75 4 641 652 (Pubitemid 23346363)
2. Degterev A., Boyce M., Yuan J., A decade of caspases Oncogene 2003 22 53 8543 8567 (Pubitemid 38028527)
3. Chowdhury I., Tharakan B., Bhat G. K., Caspases: an update Comparative Biochemistry and Physiology B 2008 151 1 10 27
4. Lavrik I. N., Golks A., Krammer P. H., Caspase: pharmacological manipulation of cell death Journal of Clinical Investigation 2005 115 10 2665 2672 (Pubitemid 41434390)
5. Boatright K. M., Salvesen G. S., Mechanisms of caspase activation Current Opinion in Cell Biology 2003 15 6 725 731 (Pubitemid 37492933)
6. Fischer U., Jnicke R. U., Schulze-Osthoff K., Many cuts to ruin: a comprehensive update of caspase substrates Cell Death and Differentiation 2003 10 1 76 100 (Pubitemid 36511834)
7. Timmer J. C., Salvesen G. S., Caspase substrates Cell Death and Differentiation 2007 14 1 66 72 (Pubitemid 44911895)
8. Alves J., Wurdak H., Garay-Malpartida H. M., Harris J. L., Occhiucci J. M., Belizrio J. E., Li J., TAF15 and the leukemia-associated fusion protein TAF15-CIZ/NMP4 are cleaved by caspases-3 and -7 Biochemical and Biophysical Research Communications 2009 384 4 495 500
9. Fernandes-Alnemri T., Litwack G., Alnemri E. S., CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 -converting enzyme Journal of Biological Chemistry 1994 269 49 30761 30764 (Pubitemid 24377553)
10. Faleiro L., Kobayashi R., Fearnhead H., Lazebnik Y., Multiple species of CPP32 and Mch2 are the major active caspases present in apoptotic cells The EMBO Journal 1997 16 9 2271 2281 (Pubitemid 27258629)
11. Yang X. H., Sladek T. L., Liu X., Butler B. R., Froelich C. J., Thor A. D., Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosis Cancer Research 2001 61 1 348 354 (Pubitemid 32095737)
12. Faleiro L., Lazebnik Y., Caspases disrupt the nuclear-cytoplasmic barrier Journal of Cell Biology 2000 151 5 951 959
13. Okuyama R., Nguyen B. C., Talora C., Ogawa E., Tommasi di Vignano A., Lioumi M., Chiorino G., Tagami H., Woo M., Dotto G. P., High commitment of embryonic keratinocytes to terminal differentiation through a Notch1-caspase 3 regulatory mechanism Developmental Cell 2004 6 4 551 562 (Pubitemid 38456183)
14. Woo M., Hakem R., Furlonger C., Hakem A., Duncan G. S., Sasaki T., Bouchard D., Lu L., Wu G. E., Paige C. J., Mak T. W., Caspase-3 regulates cell cycle in B cells: a consequence of substrate specificity Nature Immunology 2003 4 10 1016 1022 (Pubitemid 37265923)
15. Lamkanfi M., Festjens N., Declercq W., Berghe T. V., Vandenabeele P., Caspases in cell survival, proliferation and differentiation Cell Death and Differentiation 2007 14 1 44 55 (Pubitemid 44911893)
16. Santambrogio L., Potolicchio I., Fessler S. P., Wong S. H., Raposo G., Strominger J. L., Involvement of caspase-cleaved and intact adaptor protein 1 complex in endosomal remodeling in maturing dendritic cells Nature Immunology 2005 6 10 1020 1028 (Pubitemid 41486187)
17. Fernando P., Kelly J. F., Balazsi K., Slack R. S., Megeney L. A., Caspase 3 activity is required for skeletal muscle differentiation Proceedings of the National Academy of Sciences of the United States of America 2002 99 17 11025 11030 (Pubitemid 34920873)
18. Fernando P., Brunette S., Megeney L. A., Neural stem cell differentiation is dependent upon endogenous caspase 3 activity The FASEB Journal 2005 19 12 1671 1673 (Pubitemid 41429525)
19. De Botton S., Sabri S., Daugas E., Zermati Y., Guidotti J. E., Hermine O., Kroemer G., Vainchenker W., Debili N., Platelet formation is the consequence of caspase activation within megakaryocytes Blood 2002 100 4 1310 1317 (Pubitemid 34864286)
20. Zandy A. J., Lakhani S., Zheng T., Flavell R. A., Bassnett S., Role of the executioner caspases during lens development Journal of Biological Chemistry 2005 280 34 30263 30272 (Pubitemid 41216206)
21. Zermati Y., Garrido C., Amsellem S., Fishelson S., Bouscary D., Valensi F., Varet B., Solary E., Hermine O., Caspase activation is required for terminal erythroid differentiation Journal of Experimental Medicine 2001 193 2 247 254 (Pubitemid 32524456)
22. Miura M., Chen X. D., Allen M. R., Bi Y., Gronthos S., Seo B. M., Lakhani S., Flavell R. A., Feng X. H., Robey P. G., Young M., Shi S., A crucial role of caspase-3 in osteogenic differentiation of bone marrow stromal stem cells Journal of Clinical Investigation 2004 114 12 1704 1713 (Pubitemid 40385526)
23. Kulda K., Zheng T. S., Na S., Kuan C. Y., Yang D., Karasuyama H., Rakic P., Flavell R. A., Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice Nature 1996 384 6607 368 372 (Pubitemid 26408520)
24. Leonard J. R., Klocke B. J., D'sa C., Flavell R. A., Roth K. A., Strain-dependent neurodevelopmental abnormalities in caspase-3-deficient mice Journal of Neuropathology and Experimental Neurology 2002 61 8 673 677 (Pubitemid 34851770)
25. Lamkanfi M., Kanneganti T. D., Caspase-7: a protease involved in apoptosis and inflammation International Journal of Biochemistry and Cell Biology 2010 42 1 21 24
26. Lakhani S. A., Masud A., Kuida K., Porter G. A., Booth C. J., Mehal W. Z., Inayat I., Flavell R. A., Caspases 3 and 7: key mediators of mitochondrial events of apoptosis Science 2006 311 5762 847 851 (Pubitemid 43228848)
27. Walsh J. G., Cullen S. P., Sheridan C., Lthi A. U., Gerner C., Martin S. J., Executioner caspase-3 and caspase-7 are functionally distinct proteases Proceedings of the National Academy of Sciences of the United States of America 2008 105 35 12815 12819
28. Slee E. A., Adrain C., Martin S. J., Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis Journal of Biological Chemistry 2001 276 10 7320 7326
29. Rao R. V., Hermel E., Castro-Obregon S., Del Rio G., Ellerby L. M., Ellerby H. M., Bredesen D. E., Coupling endoplasmic reticulum stress to the cell death program. Mechanism of caspase activation Journal of Biological Chemistry 2001 276 36 33869 33874
30. Galande S., Dickinson L. A., Mian S., Sikorska M., Kohwi-Shigematsu T., SATB1 cleavage by caspase 6 disrupts PDZ domain-mediated dimerization, causing detachment from chromatin early in T-cell apoptosis Molecular and Cellular Biology 2001 21 16 5591 5604 (Pubitemid 32702462)
31. Eymin B., Sordet O., Droin N., Munsch B., Haugg M., Van De Craen M., Vandenabeele P., Solary E., Caspase-induced proteolysis of the cyclin-dependent kinase inhibitor p27(Kip1) mediates its anti-apoptotic activity Oncogene 1999 18 34 4839 4847 (Pubitemid 29423567)
32. Cohen L. Y., Bourbonnire M., Sabbagh L., Bouchard A., Chew T., Jeannequin P., Lazure C., Skaly R. P., Notch1 antiapoptotic activity is abrogated by caspase cleavage in dying T lymphocytes Cell Death and Differentiation 2005 12 3 243 254 (Pubitemid 40360948)
33. Nyormoi O., Wang Z., Doan D., Ruiz M., McConkey D., Bar-Eli M., Transcription factor AP-2 is preferentially cleaved by caspase 6 and degraded by proteasome during tumor necrosis factor alpha-induced apoptosis in breast cancer cells Molecular and Cellular Biology 2001 21 15 4856 4867 (Pubitemid 32656384)
34. Takahashi A., Alnemri E. S., Lazebnik Y. A., Fernandes-Alnemri T., Litwack G., Moir R. D., Goldman R. D., Poirier G. G., Kaufmann S. H., Earnshaw W. C., Cleavage of lamin a by Mch2 but not CPP32: multiple interleukin 1 -con verting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis Proceedings of the National Academy of Sciences of the United States of America 1996 93 16 8395 8400
35. Rokudai S., Fujita N., Hashimoto Y., Tsuruo T., Cleavage and inactivation of antiapoptotic Akt/PKB by caspases during apoptosis Journal of Cellular Physiology 2000 182 2 290 296 (Pubitemid 30022682)
36. Werz O., Tretiakova I., Michel A., Ulke-Lemee A., Hrnig M., Franke L., Schneider G., Samuelsson B., Rdmark O., Steinhilber D., Caspase-mediated degradation of human 5-lipoxygenase in B lymphocytic cells Proceedings of the National Academy of Sciences of the United States of America 2005 102 37 13164 13169 (Pubitemid 41324996)
37. Watanabe C., Shu G. L., Zheng T. S., Flavell R. A., Clark E. A., Caspase-6 regulates B cell activation and differentiation into plasma cells Journal of Immunology 2008 181 10 6810 6819
38. Zheng T. S., Hunot S., Kuida K., Momoi T., Srinivasan A., Nicholson D. W., Lazebnik Y., Flavell R. A., Deficiency in caspase-9 or caspase-3 induces compensatory caspase activation Nature Medicine 2000 6 11 1241 1247
39. Lee J. W., Kim M. R., Soung Y. H., Nam S. W., Kim S. H., Lee J. Y., Yoo N. J., Lee S. H., Mutational analysis of the CASP6 gene in colorectal and gastric carcinomas APMIS 2006 114 9 646 650 (Pubitemid 44337344)
40. Baumgartner R., Meder G., Briand C., Decock A., D'Arcy A., Hassiepen U., Morse R., Renatus M., The crystal structure of caspase-6, a selective effector of axonal degeneration Biochemical Journal 2009 423 3 429 439
41. Rowley J. D., A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining Nature 1973 243 5405 290 293
42. Rowley J. D., Chromosome translocations: dangerous liaisons revisited Nature Reviews Cancer 2001 1 3 245 250 (Pubitemid 33741900)
43. Nambiar M., Kari V., Raghavan S. C., Chromosomal translocations in cancer Biochimica et Biophysica Acta 2008 1786 2 139 152
44. De Braekeleer E., Ferec C., De Braekeleer M., RUNX1 translocations in malignant hemopathies Anticancer Research 2009 29 4 1031 1038
45. Wang Z. Y., Chen Z., Acute promyelocytic leukemia: from highly fatal to highly curable Blood 2008 111 5 2505 2515
46. Talpaz M., Shah N. P., Kantarjian H., Donato N., Nicoll J., Paquette R., Cortes J., O'Brien S., Nicaise C., Bleickardt E., Blackwood-Chirchir M. A., Iyer V., Chen T. T., Huang F., Decillis A. P., Sawyers C. L., Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias The New England Journal of Medicine 2006 354 24 2531 2541 (Pubitemid 43882349)
47. Di Bacco A. M. A., Cotter T. G., p53 expression in K562 cells is associated with caspase-mediated cleavage of c-ABL and BCR-ABL protein kinases British Journal of Haematology 2002 117 3 588 597 (Pubitemid 34539232)
48. Lu Y., Peng Z. G., Yuan T. T., Yin Q. Q., Xia L., Chen G. Q., Multi-sites cleavage of leukemogenic AML1-ETO fusion protein by caspase-3 and its contribution to increased apoptotic sensitivity Leukemia 2008 22 2 378 386 (Pubitemid 351250543)
49. Nervi C., Ferrara F. F., Fanelli M., Caspases mediate retinoic acid-induced degradation of the acute promyelocytic leukemia PML/RAR fusion protein Blood 1998 92 7 2244 2251 (Pubitemid 28452964)
50. Puccetti E., Ruthardt M., Acute promyelocytic leukemia: PML/RAR and the leukemic stem cell Leukemia 2004 18 7 1169 1175 (Pubitemid 39023127)
51. Warrell R. P. Jr., de The H., Wang Z. Y., Degos L., Acute promyelocytic leukemia The New England Journal of Medicine 1993 329 3 177 189 (Pubitemid 23195739)
52. Grignani F., Fagioli M., Alcalay M., Longo L., Pandolfi P. P., Donti E., Biondi A., Lo Coco F., Grignani F., Pelicci P. G., Acute promyelocytic leukemia: from genetics to treatment Blood 1994 83 1 10 25 (Pubitemid 24016510)
53. He L. Z., Tribioli C., Rivi R., Peruzzi D., Pelicci P. G., Soares V., Cattoretti G., Pandolfi P. P., Acute leukemia with promyelocytic features in PML/RAR transgenic mice Proceedings of the National Academy of Sciences of the United States of America 1997 94 10 5302 5307 (Pubitemid 27214778)
54. Zhu J., Gianni M., Kopf E., Honor N., Chelbi-Alix M., Koken M., Quignon F., Rochette-Egly C., De Th H., Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor (RAR ) and oncogenic RAR fusion proteins Proceedings of the National Academy of Sciences of the United States of America 1999 96 26 14807 14812 (Pubitemid 30019721)
55. Zhang X. W., Yan X. J., Zhou Z. R., Yang F. F., Wu Z. Y., Sun H. B., Liang W. X., Song A. X., Lallemand-Breitenbach V., Jeanne M., Zhang Q. Y., Yang H. Y., Huang Q. H., Zhou G. B., Tong J. H., Zhang Y., Wu J. H., Hu H. Y., De The' H., Chen S. J., Chen Z., Arsenic trioxide controls the fate of the PML-RAR oncoprotein by directly binding PML Science 2010 328 5975 240 243
56. Wu Y.-L., Zhou H.-C., Chen G.-Q., Molecular mechanisms of leukemia-associated protein degradation Frontiers of Medicine in China 2010 4 4 363 370
57. Nasr R., Guillemin M. C., Ferhi O., Soilihi H., Peres L., Berthier C., Rousselot P., Robledo-Sarmiento M., Lallemand-Breitenbach V., Gourmel B., Vitoux D., Pandolfi P. P., Rochette-Egly C., Zhu J., De Th H., Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation Nature Medicine 2008 14 12 1333 1342
58. D.Licht J., Acute promyelocytic leukemia-weapons of mass differentiation The New England Journal of Medicine 2009 360 9 928 930
59. Gu Z.-M., Wu Y.-L., Zhou M.-Y., Liu C.-X., Xu H.-Z., Yan H., Zhao Y., Huang Y., Sun H.-D., Chen G.-Q., Pharicin B stabilizes retinoic acid receptor- and presents synergistic differentiation induction with ATRA in myeloid leukemic cells Blood 2010 116 24 5289 5297
60. Peterson L. F., Zhang D. E., The 8;21 translocation in leukemogenesis Oncogene 2004 23 24 4255 4262 (Pubitemid 38758592)
61. Peterson L. F., Boyapati A., Ahn E. Y., Biggs J. R., Akiko J. O., Lo M. C., Yan M., Zhang D. E., Acute myeloid leukemia with the 8q22;21q22 translocation: secondary mutational events and alternative t(8;21) transcripts Blood 2007 110 3 799 805 (Pubitemid 47267414)
62. Burel S. A., Harakawa N., Zhou L., Pabst T., Tenen D. G., Zhang D. E., Dichotomy of AML1-ETO functions: growth arrest versus block of differentiation Molecular and Cellular Biology 2001 21 16 5577 5590 (Pubitemid 32702461)
63. Lu Y., Xu Y. B., Yuan T. T., Song M. G., Lbbert M., Fliegauf M., Chen G. Q., Inducible expression of AML1-ETO fusion protein endows leukemic cells with susceptibility to extrinsic and intrinsic apoptosis Leukemia 2006 20 6 987 993 (Pubitemid 43797289)
64. Li X., Xu Y. B., Wang Q., Lu Y., Zheng Y., Wang Y. C., Lbbert M., Zhao K. W., Chen G. Q., Leukemogenic AML1-ETO fusion protein upregulates expression of connexin 43: the role in AML 1-ETO-induced growth arrest in leukemic cells Journal of Cellular Physiology 2006 208 3 594 601 (Pubitemid 44141884)
65. Szyrach M., Mnchberg F. E., Riehle H., Nordheim A., Krauter J., Nagel S., Heil G., Heidenreich O., Cleavage of AML1/MTG8 by asymmetric hammerhead ribozymes European Journal of Biochemistry 2001 268 12 3550 3557 (Pubitemid 32862948)
66. Zhou G. B., Kang H., Wang L., Gao L., Liu P., Xie J., Zhang F. X., Weng X. Q., Shen Z. X., Chen J., Gu L. J., Yan M., Zhang D. E., Chen S. J., Wang Z. Y., Zhu C., Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo Blood 2007 109 8 3441 3450 (Pubitemid 46572534)
67. Wang L., Zhao W. L., Yan J. S., Liu P., Sun H. P., Zhou G. B., Weng Z. Y., Wu W. L., Weng X. Q., Sun X. J., Chen Z., Sun H. D., Chen S. J., Eriocalyxin B induces apoptosis of t(8;21) leukemia cells through NF- B and MAPK signaling pathways and triggers degradation of AML1-ETO oncoprotein in a caspase-3-dependent manner Cell Death and Differentiation 2007 14 2 306 317 (Pubitemid 46092233)
68. Gao F. H., Wang Q., Wu Y. L., Li X., Zhao K. W., Chen G. Q., c-Jun N-terminal kinase mediates AML1-ETO protein-induced connexin-43 expression Biochemical and Biophysical Research Communications 2007 356 2 505 511 (Pubitemid 46463947)
69. Yuan Y., Zhou L., Miyamoto T., Iwasaki H., Harakawa N., Hetherington C. J., Burel S. A., Lagasse E., Weissman I. L., Akashi K., Zhang D. E., AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations Proceedings of the National Academy of Sciences of the United States of America 2001 98 18 10398 10403 (Pubitemid 32803031)
70. Yan M., Kanbe E., Peterson L. F., Boyapati A., Miao Y., Wang Y., Chen I. M., Chen Z., Rowley J. D., Willman C. L., Zhang D. E., A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis Nature Medicine 2006 12 8 945 949 (Pubitemid 44175147)
71. Faderl S., Talpaz M., Estrov Z., O'Brien S., Kurzrock R., Kantarjian H. M., The biology of chronic myeloid leukemia The New England Journal of Medicine 1999 341 3 164 172 (Pubitemid 29325745)
72. Chan L. C., Karhi K. K., Rayter S. I., A novel abl protein expressed in Philadelphia chromosome positive acute lymphoblastic leukaemia Nature 1987 325 6105 635 637 (Pubitemid 17055688)
73. Ren R., Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia Nature Reviews Cancer 2005 5 3 172 183 (Pubitemid 40314949)
74. Lugo T. G., Pendergast A. M., Muller A. J., Witte O. N., Tyrosine kinase activity and transformation potency of bcr-abl oncogene products Science 1990 247 4946 1079 1082
75. Lewis J. M., Schwartz M. A., Integrins regulate the association and phosphorylation of paxillin by c-Abl Journal of Biological Chemistry 1998 273 23 14225 14230 (Pubitemid 28319134)
76. Lewis J. M., Baskaran R., Taagepera S., Schwartz M. A., Wang J. Y. J., Integrin regulation of c-Abl tyrosine kinase activity and cytoplasmic-nuclear transport Proceedings of the National Academy of Sciences of the United States of America 1996 93 26 15174 15179
77. Eisbruch A., Blick M., Evinger-Hodges M. J., Beran M., Andersson B., Gutterman J. U., Kurzrock R., Effect of differentiation-inducing agents on oncogene expression in a chronic myelogenous leukemia cell line Cancer 1988 62 6 1171 1178
78. Wetzler M., Talpaz M., Van Etten R. A., Hirsh-Ginsberg C., Beran M., Kurzrock R., Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation Journal of Clinical Investigation 1993 92 4 1925 1939 (Pubitemid 23304562)
79. Deininger M., Buchdunger E., Druker B. J., The development of imatinib as a therapeutic agent for chronic myeloid leukemia Blood 2005 105 7 2640 2653 (Pubitemid 40446252)
80. Gorre M. E., Mohammed M., Ellwood K., Hsu N., Paquette R., Nagesh Rao P., Sawyers C. L., Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification Science 2001 293 5531 876 880 (Pubitemid 32743979)
81. Druker B. J., Circumventing resistance to kinase-inhibitor therapy The New England Journal of Medicine 2006 354 24 2594 2596 (Pubitemid 43882356)
82. Gruber F. X., Hjorth-Hansen H., Mikkola I., Stenke L., Johansen T., A novel Bcr-Abl splice isoform is associated with the L248V mutation in CML patients with acquired resistance to imatinib Leukemia 2006 20 11 2057 2060 (Pubitemid 44614904)
83. Sherbenou D. W., Hantschel O., Turaga L., Kaupe I., Willis S., Bumm T., Press R. D., Superti-Furga G., Druker B. J., Deininger M. W., Characterization of BCR-ABL deletion mutants from patients with chronic myeloid leukemia Leukemia 2008 22 6 1184 1190 (Pubitemid 351833786)
84. Ma W., Kantarjian H., Yeh C. H., Zhang Z. J., Cortes J., Albitar M., BCR-ABL truncation due to premature translation termination as a mechanism of resistance to kinase inhibitors Acta Haematologica 2009 121 1 27 31
85. Arvand A., Denny C. T., Biology of EWS/ETS fusions in Ewing's family tumors Oncogene 2001 20 40 5747 5754 (Pubitemid 32928112)
86. Andersson M. K., Sthlberg A., Arvidsson Y., Olofsson A., Semb H., Stenman G., Nilsson O., man P., The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response BMC Cell Biology 2008 9, article 37
87. Martini A., La Starza R., Janssen H., Bilhou-Nabera C., Corveleyn A., Somers R., Aventin A., Fo R., Hagemeijer A., Mecucci C., Marynen P., Recurrent rearrangement of the Ewing's sarcoma gene, EWSR1, or its homologue, TAF15, with the transcription factor CIZ/NMP4 in acute leukemia Cancer Research 2002 62 19 5408 5412
88. Lee H. J., Kim S., Pelletier J., Kim J., Stimulation of hTAF68 (NTD)-mediated transactivation by v-Src FEBS Letters 2004 564 1-2 188 198 (Pubitemid 38490723)
89. Estrov Z., Thall P. F., Talpaz M., Estey E. H., Kantarjian H. M., Andreeff M., Harris D., Van Q., Walterscheid M., Kornblau S. M., Caspase 2 and caspase 3 protein levels as predictors of survival in acute myelogenous leukemia Blood 1998 92 9 3090 3097 (Pubitemid 28492314)
90. Faderl S., Thall P. F., Kantarjian H. M., Talpaz M., Harris D., Van Q., Beran M., Kornblau S. M., Pierce S., Estrov Z., Caspase 2 and caspase 3 as predictors of complete remission and survival in adults with acute lymphoblastic leukemia Clinical Cancer Research 1999 5 12 4041 4047 (Pubitemid 30013782)
91. Campos L., Sabido O., Viallet A., Vasselon C., Guyotat D., Expression of apoptosis-controlling proteins in acute leukemia cells Leukemia and Lymphoma 1999 33 5-6 499 509 (Pubitemid 29213607)
92. Svingen P. A., Karp J. E., Krajewski S., Mesner P. W., Gore S. D., Burke P. J., Reed J. C., Lazebnik Y. A., Kaufmann S. H., Evaluation of Apaf-1 and procaspases-2, -3, -7, -8, and -9 as potential prognostic markers in acute leukemia Blood 2000 96 12 3922 3931
93. Liu T., Raetz E., Moos P. J., Perkins S. L., Bruggers C. S., Smith F., Carroll W. L., Diversity of the apoptotic response to chemotherapy in childhood leukemia Leukemia 2002 16 2 223 232 (Pubitemid 34145140)
94. Green D. R., Kroemer G., Pharmacological manipulation of cell death: clinical applications in sight? Journal of Clinical Investigation 2005 115 10 2610 2617 (Pubitemid 41434383)
95. Deveraux Q. L., Reed J. C., IAP family proteinssuppressors of apoptosis Genes and Development 1999 13 3 239 252
96. Fulda S., Wick W., Weller M., Debatin K. M., Smac agonists sensitize for Apo2L/TRAIL-or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo Nature Medicine 2002 8 8 808 815
97. Thome M., Schneider P., Hofmann K., Fickenscher H., Meinl E., Neipel F., Mattmann C., Burns K., Bodmer J. L., Schrter M., Scaffidi C., Krammer P. H., Peter M. E., Tschopp J., Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors Nature 1997 386 6624 517 521 (Pubitemid 27164081)
98. Lacasse E. C., Kandimalla E. R., Winocour P., Sullivan T., Agrawal S., Gillard J. W., Durkin J., Application of XIAP antisense to cancer and other proliferative disorders: development of AEG35156/GEM640 Annals of the New York Academy of Sciences 2005 1058 215 234
99. Putt K. S., Chen G. W., Pearson J. M., Sandhorst J. S., Hoagland M. S., Kwon J. T., Hwang S. K., Jin H., Churchwell M. I., Cho M. H., Doerge D. R., Helferich W. G., Hergenrother P. J., Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy Nature Chemical Biology 2006 2 10 543 550 (Pubitemid 44413237)
100. Denault J.-B., Drag M., Salvesen G. S., Alves J., Heidt A. B., Deveraux Q., Harris J. L., Small molecules not direct activators of caspases Nature Chemical Biology 2007 3 9 519 (Pubitemid 47294403)
101. Hergenrother P.J. Putt K.S. Reply to small molecules not direct activators of caspases Nature Chemical Biology 2007 3:9 520.